Langdahl B, Chung YS, Plebanski R, Czerwinski E, et al. Proposed Denosumab Biosimilar SB16 vs Reference Denosumab in Postmenopausal Osteoporosis: Phase 3 Results Up to Month 12. J Clin Endocrinol Metab 2024 Sep 7:dgae611. doi: 10.1210.
PMID: 39243386